About Us Services Careers FAQ Contact Us 0
Home Medical Devices Hereditary Testing Market Size, Share & Growth Report 2033
Hereditary Testing Market

Hereditary Testing Market Size, Share & Trends Analysis Report By Disease Type (Hereditary Cancer Testing, Hereditary Non-cancer Testing) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRMD2280DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Hereditary Testing Market Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Hereditary Cancer Testing
        1. By Value
      3. Hereditary Non-cancer Testing
        1. By Value
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Hereditary Cancer Testing
        1. By Value
      3. Hereditary Non-cancer Testing
        1. By Value
    3. U.S.
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Hereditary Cancer Testing
          1. By Value
        3. Hereditary Non-cancer Testing
          1. By Value
    4. Canada
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Hereditary Cancer Testing
        1. By Value
      3. Hereditary Non-cancer Testing
        1. By Value
    3. U.K.
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Hereditary Cancer Testing
          1. By Value
        3. Hereditary Non-cancer Testing
          1. By Value
    4. Germany
    5. France
    6. Spain
    7. Italy
    8. Russia
    9. Nordic
    10. Benelux
    11. Rest of Europe
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Hereditary Cancer Testing
        1. By Value
      3. Hereditary Non-cancer Testing
        1. By Value
    3. China
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Hereditary Cancer Testing
          1. By Value
        3. Hereditary Non-cancer Testing
          1. By Value
    4. Korea
    5. Japan
    6. India
    7. Australia
    8. Taiwan
    9. South East Asia
    10. Rest of Asia-Pacific
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Hereditary Cancer Testing
        1. By Value
      3. Hereditary Non-cancer Testing
        1. By Value
    3. UAE
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Hereditary Cancer Testing
          1. By Value
        3. Hereditary Non-cancer Testing
          1. By Value
    4. Turkey
    5. Saudi Arabia
    6. South Africa
    7. Egypt
    8. Nigeria
    9. Rest of MEA
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Hereditary Cancer Testing
        1. By Value
      3. Hereditary Non-cancer Testing
        1. By Value
    3. Brazil
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Hereditary Cancer Testing
          1. By Value
        3. Hereditary Non-cancer Testing
          1. By Value
    4. Mexico
    5. Argentina
    6. Chile
    7. Colombia
    8. Rest of LATAM
    1. Hereditary Testing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Myriad Genetics Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Illumina Inc.
    3. Natera Inc.
    4. Invitae Corporation
    5. Laboratory Corporation of America Holdings
    6. Quest Diagnostics Incorporated
    7. F. Hoffmann-La Roche Ltd.
    8. COOPERSURGICAL INC.
    9. Agilent Technologies Inc.
    10. Thermo Fisher Scientific Inc.
    11. SOPHiA GENETICS
    12. Fulgent Genetics
    13. Twist Bioscience
    14. MedGenome
    15. CENTOGENE N.V.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Market Overview Ancestry testing, also known as genetic genealogy, is a method for assessing family history (genealogy) to verify the ancestral relationship of an individual. Evaluating DNA variations provides detailed information regarding the orig
Buy Now
Global Report
Sterility Testing Market Size The global sterility testing market size was valued at USD 1.35 billion in 2024 and is expected to grow from USD 1.46 billion in 2025 to USD 2.79 billion by 2033, growing at a CAGR of 8.4% during the fore
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.